Stellargene Technologies Private Limited - Due diligence report
A 360° intelligence report on Stellargene: trust score, financial health, credit view, compliance, directors, growth and distress signals - …
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Stellargene — 360° Intelligence Report
Generated from MCA filings & public recordsStellargene is assessed as Moderate with a Trust Score of 61/100. Stellargene is a private limited indian non-government company incorporated in 2016, operating in the Healthcare sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a high compliance risk and moderate financial risk profile.
Report generated on 31 Jul 2026 from the latest processed filings. Stellargene Technologies Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Standalone · 1 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they are- Liabilities ≈ 38% EBITDA - stretched.
- No open charges - unencumbered balance sheet.
- Working-capital cover adequate.
Charges position: 0 open (-) · 0 satisfied (-).
- Company status is "Strike Off" - not Active.
- Balance sheet slightly behind (Mar 2024).
- 1 active GST registration(s).
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| BHAGWATI SHARAN TIWARY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ASHUTOSH PASTOR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
Ownership & Group Intelligence
As per FY 2017 annual returnPromoters hold a dominant controlling stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth N/A · Distress 65Stakeholder Verdicts
Vendor · Banker · Investor- Check the compliance flags before onboarding.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance gaps should be priced into terms.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 7 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Healthrise Foundation | U85100MH2010NPL204174 | Mumbai, Maharashtra, India |
| Diagnozhub Healthcare Private Limited | U74999KA2016PTC094248 | Bangalore, Karnataka, India |
| Parrinam Ayurveda Healer Private Limited | U85191TZ2013PTC019116 | Coimbatore, Tamil Nadu, India |
| G.K.Biotec Surgicals Private Limited | U33112DL1997PTC084660 | New Delhi, Delhi, India |
| Stratino Management Private Limited | U65100DL2015PTC276851 | New Delhi, Delhi, India |
| Savelegs Industries Private Limited | U51100TG2015PTC100179 | Secunderabad, Telangana, India |
| Sorath Laser Private Limited | U85110GJ2010PTC062397 | Junagadh, Gujarat, India |
| Truway Migration Consultants Private Limited | U85100RJ2015PTC048312 | Jaipur, Rajasthan, India |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Stellargene before audits and certifications: compliance score 43/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Stellargene: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Stellargene - screening before a deeper diligence.
Vendor verdict: Review suggested. Trust score 61/100, distress signals and MSME payment-delay disclosures - know whether Stellargene pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Stellargene - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Stellargene an active company?
Stellargene has MCA status “Strike Off” with a compliance score of 43/100 (Caution Indicated).
Is Stellargene financially healthy?
Stellargene has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.
Should I do business with Stellargene?
Its overall Trust Score is 61/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Stellargene?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.
Does Stellargene have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Stellargene up to date with its ROC filings?
Balance sheet slightly behind (Mar 2024). Overall compliance score: 43/100 (Caution Indicated).
Is it risky to lend to Stellargene?
Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.